QVA149 does not increase the risk of cardio- and cerebro-vascular events, pneumonia and exacerbation events compared with placebo: A network meta-analysis across multiple safety databases Source: Annual Congress 2013 –Asthma and COPD management: novel clinical findings Year: 2013
Effect of omalizumab on the risk of hospitalisation in patients with uncontrolled severe asthma in real-life. The PAX-LASER cohort Source: Annual Congress 2010 - Aspects of severe asthma Year: 2010
Incidence and risk factors of frequent asthma exacerbations in a multinational, multidatabase cohort study Source: International Congress 2019 – Epidemiology of airway diseases in primary care Year: 2019
Risk of non-lower respiratory serious adverse events following COPD exacerbations in the 4-year UPLIFT trial Source: Annual Congress 2010 - Bronchodilator treatment for asthma and COPD Year: 2010
Time trends in clinical characteristics of patients with severe asthma: data from the Belgian Severe asthma register (BSAR) Source: International Congress 2018 – Tests and trends in asthma Year: 2018
Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events: A population-based study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
Adverse events and mortality in the INSPIRE study (investigating new standards for prophylaxis in reduction of exacerbations) Source: Eur Respir J 2007; 30: Suppl. 51, 125s Year: 2007
Using placebo-controlled trials to define predictors of future exacerbations in severe asthma patients Source: Eur Respir J, 58 (6) 2101702; 10.1183/13993003.01702-2021 Year: 2021
Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011
Is anemia associated with readmission risk in severe acute exacerbation of COPD: Preliminary results from a naturalistic cohort Source: Virtual Congress 2020 – Clinical data and COPD management Year: 2020
Acute exacerbation phenotypes of asthma and COPD: impact on clinical outcomes Source: Virtual Congress 2021 – Biomarkers to phenotype asthma: prediction of exacerbations Year: 2021
Patterns, predictors and outcomes of asthma control and exacerbations during pregnancy: a prospective cohort study Source: ERJ Open Res 2016 Year: 2016
Incidence and risk factors of pediatric asthma exacerbations in a multinational, multidatabase cohort study Source: International Congress 2018 – New developments in paediatric asthma Year: 2018
Identification of risk factors of acute cardiovascular events in acute exacerbation period for patients with COPD: a prospective nested case-control study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Premature discontinuation of patients: a potential bias in COPD clinical trials Source: Eur Respir J 2007; 30: 898-906 Year: 2007
The ARIETTA study: baseline demographics in a real-world setting in patients with severe asthma Source: International Congress 2017 – Bronchial asthma management Year: 2017
Early treatment of obstructive apnoea and stroke outcome: a randomised controlled trial Source: Eur Respir J 2011; 37: 1128-1136 Year: 2011
The coping with asthma study: a randomised controlled trial and economic evaluation of a home-based nurse intervention for adults at risk of adverse asthma outcomes Source: Eur Respir J 2003; 22: Suppl. 45, 536s Year: 2003
Study of clinical presentation and predictors of adverse outcome in patients admitted for acute exacerbation of COPD. Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma Source: Annual Congress 2005 - Severe asthma: perception and management Year: 2005